Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Marks LB, Garst J, Socinski MA, Sibley G, Blackstock AW, Herndon JE, Zhou S, Shafman T, Tisch A, Clough R, Yu X, Turrisi A, Anscher M, Crawford J, Rosenman J; Carolina Conformal Therapy Consortium. Marks LB, et al. Among authors: rosenman j. J Clin Oncol. 2004 Nov 1;22(21):4329-40. doi: 10.1200/JCO.2004.02.165. J Clin Oncol. 2004. PMID: 15514374 Clinical Trial.
The impact of local and regional disease extent on overall survival in patients with advanced stage IIIB/IV non-small cell lung carcinoma.
Higginson DS, Chen RC, Tracton G, Morris DE, Halle J, Rosenman JG, Stefanescu M, Pham E, Socinski MA, Marks LB. Higginson DS, et al. Among authors: rosenman jg. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e385-92. doi: 10.1016/j.ijrobp.2012.04.045. Epub 2012 Aug 1. Int J Radiat Oncol Biol Phys. 2012. PMID: 22857887
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Socinski MA, Marks LB, Garst J, Sibley GS, Blackstock W, Turrisi A, Herndon J, Zhou S, Anscher M, Crawford J, Shafman T, Rosenman J. Socinski MA, et al. Among authors: rosenman j. Oncologist. 2001;6 Suppl 1:20-4. doi: 10.1634/theoncologist.6-suppl_1-20. Oncologist. 2001. PMID: 11182001 Free article. Clinical Trial.
Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
Das SK, Miften MM, Zhou S, Bell M, Munley MT, Whiddon CS, Craciunescu O, Baydush AH, Wong T, Rosenman JG, Dewhirst MW, Marks LB. Das SK, et al. Among authors: rosenman jg. Med Phys. 2004 Jun;31(6):1452-61. doi: 10.1118/1.1750991. Med Phys. 2004. PMID: 15259648
144 results